

19 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/19/3240994/0/en/Traws-Pharma-Completes-Analysis-of-Ratutrelvir-Clinical-Study-in-PAXLOVID-Eligible-and-Ineligible-COVID-19-Patients-and-Provides-Updates-for-Additional-Indication-for-Tivoxavir-Mar.html